ATAI vs. PG
ATAI (Atai Life Sciences N.V.) and PG (The Procter & Gamble Company) are both stocks. ATAI operates in Biotechnology (Healthcare), while PG operates in Household & Personal Products (Consumer Defensive). Over the past 3 years, ATAI returned 29.14%/yr vs 3.69%/yr for PG. At a 0.04 correlation, their price movements are largely independent.
Performance
ATAI vs. PG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATAI achieves a -4.16% return, which is significantly lower than PG's 5.93% return.
ATAI
- 1D
- 3.16%
- 1M
- -2.97%
- YTD
- -4.16%
- 6M
- -8.62%
- 1Y
- 85.78%
- 3Y*
- 29.14%
- 5Y*
- —
- 10Y*
- —
PG
- 1D
- 0.86%
- 1M
- 4.83%
- YTD
- 5.93%
- 6M
- 6.28%
- 1Y
- -3.97%
- 3Y*
- 3.69%
- 5Y*
- 4.73%
- 10Y*
- 8.96%
ATAI vs. PG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ATAI Atai Life Sciences N.V. | -4.16% | 207.52% | -5.67% | -46.99% | -65.14% | -63.67% |
PG The Procter & Gamble Company | 5.93% | -12.26% | 17.25% | -0.86% | -5.05% | 23.61% |
Correlation
The correlation between ATAI and PG is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (All Time) Calculated using the full available price history since Jun 18, 2021 | 0.04 |
Fundamentals
ATAI:
$1.40B
PG:
$361.53B
ATAI:
-$2.67
PG:
$5.23
ATAI:
279.18
PG:
4.20
ATAI:
7.05
PG:
6.70
ATAI:
$3.49M
PG:
$86.72B
ATAI:
$3.49M
PG:
$43.64B
ATAI:
-$663.38M
PG:
$22.63B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATAI vs. PG — Risk / Return Rank
ATAI
PG
ATAI vs. PG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATAI | PG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.29 | ||
| Sortino ratioReturn per unit of downside risk | +2.19 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.97 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | -0.37 | +2.04 |
| Martin ratioReturn relative to average drawdown | 2.66 | -0.68 | +3.34 |
Loading charts...
Drawdowns
ATAI vs. PG - Drawdown Comparison
The maximum ATAI drawdown since its inception was -95.05%, which is greater than PG's maximum drawdown of -54.25%. Use the drawdown chart below to compare losses from any high point for ATAI and PG.
Loading charts...
Drawdown Indicators
| ATAI | PG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.05% | -54.25% | -40.80% |
Max Drawdown (1Y)Largest decline over 1 year | -48.06% | -15.52% | -32.54% |
Max Drawdown (3Y)Largest decline over 3 years | -59.23% | -21.15% | -38.08% |
Max Drawdown (5Y)Largest decline over 5 years | — | -23.77% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -23.77% | — |
Current DrawdownCurrent decline from peak | -81.33% | -13.29% | -68.04% |
Average DrawdownAverage peak-to-trough decline | -80.78% | -12.16% | -68.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.10% | 8.80% | +21.30% |
Volatility
ATAI vs. PG - Volatility Comparison
Atai Life Sciences N.V. (ATAI) has a higher volatility of 20.22% compared to The Procter & Gamble Company (PG) at 6.99%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATAI | PG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.22% | 6.99% | +13.23% |
Volatility (6M)Calculated over the trailing 6-month period | 50.17% | 15.01% | +35.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.21% | 18.78% | +62.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 83.71% | 17.82% | +65.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.71% | 19.05% | +64.66% |
Dividends
ATAI vs. PG - Dividend Comparison
ATAI has not paid dividends to shareholders, while PG's dividend yield for the trailing twelve months is around 2.85%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ATAI Atai Life Sciences N.V. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PG The Procter & Gamble Company | 2.85% | 2.91% | 2.36% | 2.55% | 2.38% | 2.08% | 2.24% | 2.37% | 3.09% | 2.98% | 3.18% | 3.31% |
Financials
ATAI vs. PG - Financials Comparison
This section allows you to compare key financial metrics between Atai Life Sciences N.V. and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATAI and PG have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATAI has higher volatility (20.22%) compared to PG (6.99%). In terms of maximum drawdown, ATAI dropped -95.05% vs PG's -54.25%.
ATAI currently has the higher Sharpe Ratio (0.99 vs -0.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATAI and PG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer